You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 3, February 10, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (53)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •End-of-life Care/ Palliative Medicine
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sedative Use in the Last Week of Life and the Implications for End-of-Life Decision Making

Nigel Sykes, MA, BM, BCh, FRCGP; Andrew Thorns, MBBS, MA, MRCGP

Arch Intern Med. 2003;163:341-344.

Background  The use of sedation at the end of life has aroused ethical controversy, attracting accusations of hastening death by gradually increasing sedative doses. The doctrine of double effect has been introduced as an ethical defense. This study aimed to determine how sedative doses change at the end of life and how often the doctrine of double effect might be relevant.

Methods  Case note review was performed of 237 consecutive patients who died in a specialist palliative care unit. Sedative dose changes during the last week of life were noted and survival from admission was compared between groups of patients receiving no sedation, sedation for 7 days, or a commencement of sedation in the last 48 hours of life. There was detailed review of notes from patients who received a marked increase in sedative dose to explore the applicability of the doctrine of double effect.

Results  Sedation was given to 48% of patients. Of these, 13% received sedatives for 7 days or more, while 56% commenced sedative use only in the last 48 hours of life. The groups receiving no sedation or sedation for less than 48 hours had the shortest survival from admission (mean, 14.3 and 14.2 days), whereas the 7-day sedation group survived for a mean of 36.6 days (P<.001). Sedative use and dose increased toward the end of life, but the detailed case note review disclosed only 2 cases where the doctrine of double effect may have been implicated.

Conclusion  Sedative dose increases in the last hours of life were not associated with shortened survival overall, suggesting that the doctrine of double effect rarely has to be invoked to excuse sedative prescribing in end-stage care.


From St Christopher's Hospice, London, England. Dr Thorns is now with Pilgrims Hospices and East Kent Hospitals National Health Service Trust, Margate, England.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Introduction of the Liverpool Care Pathway for end of life care to emergency medicine
Paterson et al.
Emerg. Med. J. 2009;26:777-779.
ABSTRACT | FULL TEXT  

European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care
Cherny et al.
Palliat Med 2009;23:581-593.
ABSTRACT  

Palliative sedation therapy does not hasten death: results from a prospective multicenter study
Maltoni et al.
Ann Oncol 2009;20:1163-1169.
ABSTRACT | FULL TEXT  

The use of sedation to relieve cancer patients' suffering at the end of life: addressing critical issues
Cherny
Ann Oncol 2009;20:1153-1155.
FULL TEXT  

Changed Patterns in Dutch Palliative Sedation Practices After the Introduction of a National Guideline
Hasselaar et al.
Arch Intern Med 2009;169:430-437.
ABSTRACT | FULL TEXT  

Agitation and Delirium at the End of Life: "We Couldn't Manage Him"
Breitbart and Alici
JAMA 2008;300:2898-2910.
ABSTRACT | FULL TEXT  

The use of sedative drugs at the end of life in a UK hospice
Stephenson
Palliat Med 2008;22:969-970.
 

Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study
Reuzel et al.
Palliat Med 2008;22:641-646.
ABSTRACT  

Dealing With Delicate Issues in Continuous Deep Sedation: Varying Practices Among Dutch Medical Specialists, General Practitioners, and Nursing Home Physicians
Hasselaar et al.
Arch Intern Med 2008;168:537-543.
ABSTRACT | FULL TEXT  

Terminal sedation and the "imminence condition"
Cellarius
J. Med. Ethics 2008;34:69-72.
ABSTRACT | FULL TEXT  

Having a difficult time leaving: experiences and attitudes of nurses with palliative sedation
Rietjens et al.
Palliat Med 2007;21:643-649.
ABSTRACT  

Improving Prescription in Palliative Sedation: Compliance With Dutch Guidelines
Hasselaar et al.
Arch Intern Med 2007;167:1166-1171.
ABSTRACT | FULL TEXT  

Lethal opioids or dangerous prescribers?
George and Regnard
Palliat Med 2007;21:77-80.
 

The Ethics of Palliative Sedation as a Therapy of Last Resort
National Ethics Committee, Veterans Health Adminis
AM J HOSP PALLIAT CARE 2007;23:483-491.
ABSTRACT  

Palliative Sedation in Dying Patients: "We Turn to It When Everything Else Hasn't Worked"
Lo and Rubenfeld
JAMA 2005;294:1810-1816.
ABSTRACT | FULL TEXT  

Legalised euthanasia will violate the rights of vulnerable patients
George et al.
BMJ 2005;331:684-685.
FULL TEXT  

Medical house officers' attitudes toward vigorous analgesia, terminal sedation, and physician-assisted suicide
Kaldjian et al.
AM J HOSP PALLIAT CARE 2004;21:381-387.
ABSTRACT  

Emotional burden of nurses in palliative sedation therapy
Morita et al.
Palliat Med 2004;18:550-557.
ABSTRACT  

Physician Reports of Terminal Sedation without Hydration or Nutrition for Patients Nearing Death in the Netherlands
Rietjens et al.
ANN INTERN MED 2004;141:178-185.
ABSTRACT | FULL TEXT  

End-of-Life Practices in European Intensive Care Units
Kompanje
JAMA 2003;290:2938-2939.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.